Sign inJoin waitlistJoin the waitlist

Sukeshi Arora

Leader Gastrointestinal Malignancies · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine

Credentials: · · · · ·

History

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Present
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Present

Hematology and Medical Oncology
University of Texas Health Science Center at San Antonio
2011–2014
Internal Medicine
University of Texas Health Science Center at San Antonio
2008–2011
Univ of Texas Southwestern Med Sch at Dallas
2004–2008

Research

Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
Clinical Cancer Research · 2020 · 157 citations
Review: Oncolytic virotherapy, updates and future directions
Review · Oncotarget · 2017 · 97 citations
Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease
The Journal of Infectious Diseases · 2005 · 82 citations

Devalingam Mahalingam
13 papers
John Sarantopoulos
5 papers
Francisco Cigarroa
4 papers
GW
Grant Williams
4 papers
Neil Newman
4 papers
Anand Karnad
3 papers
CF
Christos Fountzilas
3 papers · 2 as a fellow
CC
Colin Court
3 papers
Kah Loh
3 papers
AS
Anthony Shields
2 papers
Arthur Winer
2 papers · 1 as a fellow
AG
Axel Grothey
2 papers

Clinical trials

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
Principal investigator · Recruiting · Phase 2
The University of Texas Health Science Center at San Antonio
2024–2027
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Principal investigator · Recruiting
The University of Texas Health Science Center at San Antonio
2019–2027
Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer
Principal investigator · Completed · Phase 2
The University of Texas Health Science Center at San Antonio
2017–2025
Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Principal investigator · Completed · Phase 1
Oncolytics Biotech
2015–2018